Related Experiment Videos
Testosterone and dementia: too much ado about too little data
Osvaldo P Almeida1, Leon Flicker
1School of Psychiatry and Clinical Neurosciences, University of Western Australia, Royal Perth Hospital, Perth, Australia.
The Journal of the British Menopause Society
|December 13, 2003
Summary
Testosterone may protect the brain and reduce Alzheimer's disease (AD) markers. However, current clinical studies show a weak and inconsistent link between testosterone levels and cognitive function or AD risk.
Area of Science:
- Neuroscience
- Endocrinology
- Gerontology
Background:
- In vitro and animal studies suggest testosterone has neuroprotective effects.
- Testosterone may reduce beta-amyloid and tau phosphorylation, key in Alzheimer's disease (AD) pathology.
- These findings imply a potential role for testosterone in cognitive function and AD risk modulation.
Purpose of the Study:
- To evaluate the clinical evidence for an association between testosterone and cognitive function/AD.
- To synthesize findings from cross-sectional studies and randomized trials on testosterone supplementation and cognition in older men.
Main Methods:
- Review of existing cross-sectional studies.
- Analysis of five randomized trials of testosterone supplementation in healthy older men.
- Examination of cognitive domains including visuospatial skills and memory.
Main Results:
- Testosterone showed a weak association with visuospatial and memory scores.
- Findings were inconsistent across studies, with multiple comparisons across various cognitive domains.
- Serum and brain testosterone levels in men with AD were comparable to controls.
Conclusions:
- Current clinical evidence does not support a strong association between testosterone and cognitive function.
- The role of testosterone in Alzheimer's disease pathogenesis requires further investigation.
- Existing data is insufficient to establish testosterone as a significant modulator of cognitive decline or AD risk in men.